Kenichiro Enooku

3.4k total citations · 2 hit papers
59 papers, 2.1k citations indexed

About

Kenichiro Enooku is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kenichiro Enooku has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hepatology, 42 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Kenichiro Enooku's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (29 papers) and Hepatitis C virus research (16 papers). Kenichiro Enooku is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (29 papers) and Hepatitis C virus research (16 papers). Kenichiro Enooku collaborates with scholars based in Japan, United States and Ukraine. Kenichiro Enooku's co-authors include Kazuhiko Koike, Ryosuke Tateishi, Hayato Nakagawa, Shuichiro Shiina, Koji Uchino, Yuji Kondo, Yoshinari Asaoka, Haruhiko Yoshida, Masaya Sato and Ryota Masuzaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Kenichiro Enooku

59 papers receiving 2.1k citations

Hit Papers

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-... 2011 2026 2016 2021 2011 2015 100 200 300 400 500

Peers

Kenichiro Enooku
Kenichiro Enooku
Citations per year, relative to Kenichiro Enooku Kenichiro Enooku (= 1×) peers Naoto Fujiwara

Countries citing papers authored by Kenichiro Enooku

Since Specialization
Citations

This map shows the geographic impact of Kenichiro Enooku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichiro Enooku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichiro Enooku more than expected).

Fields of papers citing papers by Kenichiro Enooku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichiro Enooku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichiro Enooku. The network helps show where Kenichiro Enooku may publish in the future.

Co-authorship network of co-authors of Kenichiro Enooku

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichiro Enooku. A scholar is included among the top collaborators of Kenichiro Enooku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichiro Enooku. Kenichiro Enooku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Masaya, Makoto Moriyama, Tsuyoshi Fukumoto, et al.. (2023). Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation. Hepatology International. 18(1). 131–137. 9 indexed citations
2.
Fukumoto, Tsuyoshi, Tatsuya Minami, Makoto Moriyama, et al.. (2022). Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals. Hepatology Communications. 6(9). 2496–2512. 4 indexed citations
3.
Sato, Masaya, Ryosuke Tateishi, Makoto Moriyama, et al.. (2022). Machine Learning–Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation. SHILAP Revista de lepidopterología. 1(1). 29–37. 6 indexed citations
4.
Nakatsuka, T., Hayato Nakagawa, Yuki Hayata, et al.. (2021). Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma. Journal of Gastroenterology. 56(5). 456–469. 19 indexed citations
5.
Okushin, Kazuya, Rie Suzuki, Takeya Tsutsumi, et al.. (2021). Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital. BMC Infectious Diseases. 21(1). 399–399. 3 indexed citations
6.
Okushin, Kazuya, Takeya Tsutsumi, Kazuhiko Ikeuchi, et al.. (2020). Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet. PLoS ONE. 15(8). e0234750–e0234750. 13 indexed citations
7.
Enooku, Kenichiro, Hayato Nakagawa, Naoto Fujiwara, et al.. (2019). Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. Scientific Reports. 9(1). 10663–10663. 72 indexed citations
8.
Minami, Tatsuya, Ryosuke Tateishi, Ryo Nakagomi, et al.. (2018). Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy. Journal of Hepatology. 70(1). 78–86. 62 indexed citations
9.
Okushin, Kazuya, Takeya Tsutsumi, Kazuhiko Ikeuchi, et al.. (2018). Helicobacter pyloriinfection and liver diseases: Epidemiology and insights into pathogenesis. World Journal of Gastroenterology. 24(32). 3617–3625. 45 indexed citations
10.
Tsutsumi, Takeya, Kazuya Okushin, Kenichiro Enooku, et al.. (2017). Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver. PLoS ONE. 12(1). e0170461–e0170461. 2 indexed citations
11.
Enooku, Kenichiro, Baasanjav Uranbileg, Hitoshi Ikeda, et al.. (2016). Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels. PLoS ONE. 11(9). e0161825–e0161825. 33 indexed citations
12.
Uranbileg, Baasanjav, Hitoshi Ikeda, Makoto Kurano, et al.. (2016). Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence. PLoS ONE. 11(2). e0149462–e0149462. 47 indexed citations
13.
Minami, Tatsuya, Ryosuke Tateishi, Ryo Nakagomi, et al.. (2015). Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients. Medicine. 94(23). e901–e901. 11 indexed citations
14.
Fujiwara, Naoto, Hayato Nakagawa, Yotaro Kudo, et al.. (2015). Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. Journal of Hepatology. 63(1). 131–140. 544 indexed citations breakdown →
15.
Fujiwara, Naoto, Ryosuke Tateishi, Mayuko Kondo, et al.. (2014). Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. JONA The Journal of Nursing Administration. 44. 1039–1046. 1 indexed citations
16.
Fujiwara, Naoto, Ryosuke Tateishi, Mayuko Kondo, et al.. (2014). Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. European Journal of Gastroenterology & Hepatology. 26(9). 1039–1046. 10 indexed citations
18.
Ohkawa, Ryunosuke, Hayato Nakagawa, Yumiko Satoh, et al.. (2012). Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence. Journal of Hepatology. 57(2). 330–336. 14 indexed citations
19.
Arano, Toru, Hayato Nakagawa, Ryosuke Tateishi, et al.. (2010). Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. International Journal of Cancer. 129(9). 2226–2235. 73 indexed citations
20.
Goto, Eriko, Ryosuke Tateishi, Shuichiro Shiina, et al.. (2010). Hemorrhagic Complications of Percutaneous Radiofrequency Ablation for Liver Tumors. Journal of Clinical Gastroenterology. 44(5). 374–380. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026